Abstract:Rationale: Enhancer RNA (eRNA) bi-directionally expresses from enhancer region and sense eRNA regulates adjacent mRNA in cis and in trans. However, it has remained unclear whether antisense eRNAs in different direction are functional or merely a reflection of enhancer activation.Methods: Strand-specific, ribosome-minus RNA sequencing (RNA-seq) were performed in AR positive prostate cancer cells. RNA-seq, GRO-seq, ChIP-seq, 4C-seq and DNA-methylation-seq that published in our and other labs were re-analyzed to define bi-directional enhancer RNA and DNA methylation regions. Molecular mechanisms were demonstrated by 3C, ChIP, ChIRP, CLIP, RT-PCR and western blot assays. The biological functions of antisense-eRNA were assessed using mice xenograft model and RT-PCR analysis in human tissues.Results: In this study, we identified that antisense eRNA was regulated by androgen receptor (AR) activity in prostate cancer cells. Antisense eRNA negatively regulated antisense ncRNA in AR-related target genes' loci, through recruiting DNMT1 on the antisense enhancer in the gene-ending regions and elevating DNA methylation. Importantly, the chromatin exhibited a double looping manner that facilitated sense-eRNA to promoter and antisense-eRNA to gene-ending region in cis. Depletion of antisense eRNA impaired its neighbor mRNA expression, cancer growth and invasion. The expressions of antisense eRNA were correlated with biochemical recurrence and clinical marker PSA's levels in patients' tissues.Conclusions: The findings indicated that antisense eRNA was a functional RNA and may be a novel target that when suppressed improved prostate cancer therapy and diagnosis. New chromatin interaction among enhancer, promoter and gene-ending region might provide new insight into the spatiotemporal mechanism of the gene transcription and acting of bi-directional eRNAs.

Systematic functional characterization of antisense eRNA of protocadherin α composite enhancer

Mechanism of HS5-1 eRNA Regulation of Protocadherin α Cluster via R-loop Formation

Additional evidence of HS5-1 enhancer eRNA PEARL for protocadherin alpha gene regulation

Assessing eRNAs associated with a cytokine-sensing mammary super-enhancer

Functional Assessment of CTCF Sites at Cytokine-Sensing Mammary Enhancers Using CRISPR/Cas9 Gene Editing in Mice.

CTCF/cohesin-mediated DNA Looping is Required for Protocadherin Α Promoter Choice

Functional roles of antisense enhancer RNA for promoting prostate cancer progression

RNA Exosome-Regulated Long Non-Coding RNA Transcription Controls Super-Enhancer Activity.

Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing

An RNA architectural locus control region involved in Dscam mutually exclusive splicing

Enhancer RNAs Mediate Estrogen-Induced Decommissioning of Selective Enhancers by Recruiting Erα and Its Cofactor

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

Enhancer RNAs: a missing regulatory layer in gene transcription

Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus

Transcriptional Regulation of E-cadherin by Small Activating RNA: A New Double-Stranded RNA.

Enhancers as non-coding RNA transcription units: recent insights and future perspectives

Enhancer RNAs predict enhancer–gene regulatory links and are critical for enhancer function in neuronal systems

Enhancer RNA: What We Know and What We Can Achieve

A New Class of Temporarily Phenotypic Enhancers Identified by CRISPR/Cas9-mediated Genetic Screening.

Analysis of estrogen-regulated enhancer RNAs identifies a functional motif required for enhancer assembly and gene expression

Mechanism of REST/NRSF regulation of clustered protocadherin α genes